Financials Holy Stone Healthcare Co., Ltd.

Equities

4194

TW0004194006

Pharmaceuticals

End-of-day quote Taipei Exchange 23:00:00 14/05/2024 BST 5-day change 1st Jan Change
20.3 TWD -0.73% Intraday chart for Holy Stone Healthcare Co., Ltd. -3.56% +3.71%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,136 1,276 2,688 3,154 3,794 2,407
Enterprise Value (EV) 1 874.3 853.6 2,364 2,989 3,372 2,398
P/E ratio -5.59 x -5.13 x -20.9 x -17.4 x -24 x -9.23 x
Yield - - - - - -
Capitalization / Revenue 6.57 x 6.25 x 12.1 x 14.5 x 14 x 10.2 x
EV / Revenue 5.06 x 4.18 x 10.7 x 13.8 x 12.5 x 10.1 x
EV / EBITDA -5.72 x -4.91 x -19.9 x -18 x -24 x -8.56 x
EV / FCF -10.1 x -6.62 x -44 x -42.1 x -38.4 x -15.1 x
FCF Yield -9.93% -15.1% -2.27% -2.38% -2.6% -6.6%
Price to Book 3.19 x 2.22 x 5.96 x 11.9 x 7.26 x 28.9 x
Nbr of stocks (in thousands) 78,658 108,795 108,795 108,795 122,978 122,978
Reference price 2 14.44 11.73 24.71 28.99 30.85 19.57
Announcement Date 19/03/19 19/03/20 18/03/21 22/03/22 24/02/23 26/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 172.8 204.2 221.6 217.1 270.2 236.9
EBITDA 1 -152.8 -174 -119 -166.4 -140.6 -280.1
EBIT 1 -170.6 -187.3 -128.8 -175.5 -149 -288.6
Operating Margin -98.71% -91.75% -58.12% -80.83% -55.12% -121.83%
Earnings before Tax (EBT) 1 -172.5 -187.5 -126.1 -176.1 -146.4 -284.4
Net income 1 -174.5 -190.6 -128.8 -181.3 -152.9 -289.4
Net margin -100.96% -93.36% -58.1% -83.52% -56.59% -122.15%
EPS 2 -2.584 -2.289 -1.183 -1.667 -1.285 -2.120
Free Cash Flow 1 -86.86 -128.9 -53.7 -71.02 -87.84 -158.4
FCF margin -50.25% -63.13% -24.23% -32.72% -32.51% -66.86%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19/03/19 19/03/20 18/03/21 22/03/22 24/02/23 26/03/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 262 423 324 165 422 8.77
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -86.9 -129 -53.7 -71 -87.8 -158
ROE (net income / shareholders' equity) -61.8% -40.9% -25.1% -50.7% -38.9% -95.5%
ROA (Net income/ Total Assets) -29.5% -22.2% -13.7% -25.3% -19.4% -44.3%
Assets 1 592 858.4 942.5 715.4 786.4 653.9
Book Value Per Share 2 4.530 5.300 4.150 2.430 4.250 0.6800
Cash Flow per Share 2 3.390 4.190 3.230 1.780 3.620 0.7000
Capex 1 0.45 3.26 0.91 4.29 2.15 3.53
Capex / Sales 0.26% 1.6% 0.41% 1.97% 0.8% 1.49%
Announcement Date 19/03/19 19/03/20 18/03/21 22/03/22 24/02/23 26/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 4194 Stock
  4. Financials Holy Stone Healthcare Co., Ltd.